The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia.
The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Cell Rep. 2020 Mar 31;30(13):4343-4354.e4. doi: 10.1016/j.celrep.2020.03.032.
Plasmodium sporozoites infect the liver and develop into exoerythrocytic merozoites that initiate blood-stage disease. The hepatocyte molecular pathways that permit or abrogate parasite replication and merozoite formation have not been thoroughly explored, and a deeper understanding may identify therapeutic strategies to mitigate malaria. Cellular inhibitor of apoptosis (cIAP) proteins regulate cell survival and are co-opted by intracellular pathogens to support development. Here, we show that cIAP1 levels are upregulated during Plasmodium liver infection and that genetic or pharmacological targeting of cIAPs using clinical-stage antagonists preferentially kills infected hepatocytes and promotes immunity. Using gene-targeted mice, the mechanism was defined as TNF-TNFR1-mediated apoptosis via caspases 3 and 8 to clear parasites. This study reveals the importance of cIAPs to Plasmodium infection and demonstrates that host-directed antimalarial drugs can eliminate liver parasites and induce immunity while likely providing a high barrier to resistance in the parasite.
疟原虫孢子感染肝脏并发育成外红细胞裂殖子,引发血液期疾病。允许或阻止寄生虫复制和裂殖子形成的肝细胞分子途径尚未得到彻底探索,更深入的了解可能会确定减轻疟疾的治疗策略。细胞凋亡抑制剂 (cIAP) 蛋白调节细胞存活,并被细胞内病原体利用来支持其发育。在这里,我们发现 cIAP1 水平在疟原虫肝脏感染期间上调,并且使用临床阶段拮抗剂对 cIAP 进行基因或药物靶向治疗,可优先杀死受感染的肝细胞并促进免疫。通过基因靶向小鼠,该机制被定义为通过半胱天冬酶 3 和 8 介导的 TNF-TNFR1 凋亡来清除寄生虫。这项研究揭示了 cIAP 对疟原虫感染的重要性,并证明了宿主定向抗疟药物可以消除肝脏寄生虫并诱导免疫,同时可能为寄生虫提供高抗性障碍。